全文获取类型
收费全文 | 2086篇 |
免费 | 97篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 105篇 |
妇产科学 | 28篇 |
基础医学 | 244篇 |
口腔科学 | 41篇 |
临床医学 | 124篇 |
内科学 | 455篇 |
皮肤病学 | 44篇 |
神经病学 | 86篇 |
特种医学 | 150篇 |
外科学 | 337篇 |
综合类 | 8篇 |
预防医学 | 71篇 |
眼科学 | 34篇 |
药学 | 110篇 |
肿瘤学 | 343篇 |
出版年
2023年 | 7篇 |
2022年 | 34篇 |
2021年 | 61篇 |
2020年 | 28篇 |
2019年 | 33篇 |
2018年 | 41篇 |
2017年 | 44篇 |
2016年 | 23篇 |
2015年 | 45篇 |
2014年 | 59篇 |
2013年 | 57篇 |
2012年 | 104篇 |
2011年 | 153篇 |
2010年 | 72篇 |
2009年 | 66篇 |
2008年 | 96篇 |
2007年 | 105篇 |
2006年 | 120篇 |
2005年 | 135篇 |
2004年 | 106篇 |
2003年 | 89篇 |
2002年 | 110篇 |
2001年 | 31篇 |
2000年 | 42篇 |
1999年 | 37篇 |
1998年 | 29篇 |
1997年 | 17篇 |
1996年 | 29篇 |
1995年 | 18篇 |
1994年 | 18篇 |
1993年 | 21篇 |
1992年 | 30篇 |
1991年 | 32篇 |
1990年 | 35篇 |
1989年 | 37篇 |
1988年 | 20篇 |
1987年 | 24篇 |
1986年 | 16篇 |
1985年 | 13篇 |
1984年 | 12篇 |
1983年 | 15篇 |
1982年 | 14篇 |
1979年 | 12篇 |
1974年 | 7篇 |
1972年 | 9篇 |
1971年 | 12篇 |
1969年 | 12篇 |
1968年 | 5篇 |
1967年 | 10篇 |
1966年 | 8篇 |
排序方式: 共有2192条查询结果,搜索用时 15 毫秒
1.
2.
Peroxisome proliferator-activated receptor delta (PPARdelta), a novel target site for drug discovery in metabolic syndrome. 总被引:5,自引:0,他引:5
Sadao Takahashi Toshiya Tanaka Tatsuhiko Kodama Juro Sakai 《Pharmacological research》2006,53(6):501-507
The development of new treatments for metabolic syndrome is urgent project for decreasing the prevalence of coronary heart disease and diabetes mellitus in the advanced countries. Peroxisome proliferator-activated receptor (PPAR)alpha and gamma agonists have shed light on the treatment of hypertriglyceridemia and type 2 diabetes mellitus, respectively. Among PPARs, analysis of the PPARdelta functions is lagging behind because specific PPARdelta agonists have not been developed. The appearance of new PPARdelta agonists is brightening the prospects for elucidating the physiological role of PPARdelta. PPARdelta is a new target for the treatment of metabolic syndrome. In particular, the fact that fatty acid oxidation and energy dissipation in skeletal muscle and adipose tissue by PPARdelta agonists lead to improved lipid profile, reduced adiposity and insulin sensitivity is a breakthrough. It seems that treatment of PPARdelta agonists operate similarly to the caloric restriction and prolonged exercise. We suggest that the physiological role of PPARdelta may be an indicator for switching from glucose metabolism to fatty acid metabolism. To receive new benefits of PPARdelta agonists against metabolic syndrome by increasing fatty acid consumption in skeletal muscle and adipose tissue, we need to unveil more details on the functions of PPARdelta itself and its agonists in the future. 相似文献
3.
Masao Miyagawa Shuji Tanada Ken Hamamoto 《European journal of nuclear medicine and molecular imaging》1991,18(5):332-338
To evaluate the usefulness of myocardial scintigraphy as a monitoring tool for chronic doxorubicin (DXR) cardiotoxicity, a rat model was used to investigate the relationship between the myocardial uptake of thallium 201 (Tl) or rechnetium 99m pyrophosphate (99mTc-PPi) and histological changes of the heart. Although there was no significant difference in myocardial Tl uptake between control and DXR-treated rats at an early phase after Tl injection, late-phase Tl uptake was significantly higher in the DXR-treated rats than in the control rats, indicating a slow wash-out of Tl from the myocardium. The wash-out rate calculated from scintigraphic examination of DXR-treated rats was significantly decreased with increasing degree of cardiomyopathy. Since the Tl wash-out rate was sharply decreased even in animals with minimal histological changes, it may be a possible monitoring tool for the early detection of chronic DXR cardiotoxicity. On the other hand, myocardial99mTc-PPi images could be obtained only in rats with severe myocardial changes and hence would not useful for early detection. 相似文献
4.
5.
Masaaki Kataoka Masashi Kawamura Takaharu Tsuda Hisao Itoh Akira Komatsu Shuji Tanada Atsushi lio Ken Hamamoto 《European journal of nuclear medicine and molecular imaging》1990,17(3-4):142-147
To evaluate the clinical usefulness of gallium 67 imaging in the detection of gastrointestinal (GI) non-Hodgkin's lymphoma (NHL) and in the assessment of the therapeutic effects, images were reviewed in 24 cases (25 lesions: stomach, 20; ileum, 2; and terminal ileum and/or cecum, 3) and were compared using barium studies and, in 16 cases, computerized tomography (CT). In all, 23 (92.0%) of the 25 lesions were detected by67Ga citrate imaging, the barium studies detected all 25, and CT detected 15 of 16 lesions (93.8%). The two lesions not identified by imaging and the one not found by CT were the smallest of all. In 2 (8.7%) of the 23 lesions positively identified by67Ga-citrate imaging, both CT and imaging revealed the extent of the tumor more accurately than did the barium studies. In all but one of the patients, a close correlation existed between the imaging results and the therapeutic effects. These data suggest that67Ga imaging is useful in conjunction with CT and barium studies for the detection of GI NHL and for the assessment of both the spatial extent of disease and the therapeutic effects, although a lack of67Ga uptake after therapy does not always indicate a good therapeutic effect. 相似文献
6.
7.
Following a preliminary study in healthy blood donors, we have performed serological HLA-A, B, C, DR and DQ typing using recombinant IL-2 activated T lymphocytes (IL-2.aTLs) in pediatric candidates for allogeneic bone marrow transplantation. In such patients, it is often difficult to obtain the quantity of lymphocytes required for HLA typing, particularly for class II typing using B lymphocytes, considering the timing of sampling and the volume of blood to be collected. Peripheral blood mononuclear cells (PBMCs) were activated and expanded with IL-2 until a sufficient number of IL-2.aTLs of good viability were available for the typing. In the first 10 cases, analyses of surface markers (CD2, CD20, CD25, CD36, HLA-DR and HLA-DQ, CD2/HLA-DR: two color) of IL-2.aTLs were done using flow cytometry at the time of HLA typing and indicated that IL-2.aTLs expressed HLA-DR and DQ antigens sufficient for evaluation. A small number (less than 10(6] of fresh or cryopreserved PBMCs, even those containing leukemic blast cells, were sufficient to induce and expand IL-2.aTLs for HLA typing. To date we have been able to successfully HLA-A, B, C, DR and DQ type 20/20 pediatric candidates. The HLA antigens identified on the patients' IL-2.aTLs were confirmed by a family study. 相似文献
8.
Isao Hamamoto Shunichi Takaya Satoru Todo Oscar Bronsther Shiro Fujita Thomas M. Van Gulik Kenjiro Nakamura William Irish Thomas E. Starzl 《Transplant international》1994,7(2):89-95
Sixty-eight primary liver grafts were analyzed to see whether adenine nucleotides (AN: ATP, ADP, and AMP) or purine catabolites (PC: adenosine, inosine, hypoxanthine, and xanthine) of tissue or effluent can predict primary graft nonfunction. AN, PC, and nicotinamide adenine dinucleotide, oxidized form (NAD+) of the tissue before (pretransplant) and after graft reperfusion (post-transplant) and of the effluent were analyzed. The graft outcome was classified into two groups (group A: successful, n=64; group B: primary nonfunctioning, n=4). No significant differences were observed in pretransplant measurements between groups A and B, whereas ATP, ADP, total AN, total AN+total PC (T) and NAD+, in post-transplant tissues, were significantly higher in group A. Xanthine in the effluent was significantly higher in group B than in group A. ATP, ADP, total AN, T, and NAD+ in post-transplant tissue were significantly associated with primary graft nonfunction by logistic regression analysis. 相似文献
9.
10.
Seiji Kinugasa Shuichi Tachibana Manpei Kawakami Tatsuhiko Orino Ryuichi Yamamoto Shinjiro Sasaki 《Surgery today》1998,28(3):335-338
(Received for publication on Nov. 14, 1996; accepted on May 12, 1997) 相似文献